What is Ceva's granted (in shares)?

Ceva (CEVA) reported granted (in shares) of 0 in Q1 2026.

What does granted (in shares) mean?

The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.

Ceva CEVA Granted (in shares)

Granted (in shares) at other companies

WingstopWING

0—

Oruka Therapeutics, Inc.ORKA

1.5M-12.6%

LivaNovaLIVN

957.7K+31.3%

The Hanover Insurance GroupTHG

148.1K+5.5%

GenpactG

0—

Ondas, Inc. ONDS

7.4M+45.6%

Other financials

Income statement

See full

Revenue$27.0M+11.5%

Gross profit$23.3M+12.2%

Operating income-$5.1M-16.0%

Net income-$4.5M-34.0%

EPS (diluted)-$0.21-200%

Balance sheet

See full

Cash & equivalents$21.4M+13.6%

Total debt$16.9M+249%

Total equity$338.2M+25.7%

Total assets$388.2M+25.2%

Cash flow

See full

Operating cash flow-$4.9M+34.0%

CapEx$2.3M+644%

Free cash flow-$7.2M+6.7%

Valuation

See full

Market cap$1.25B+154%

Enterprise value$1.25B+161%

P/S11.2×+6.6×

Profitability

See full

Gross margin89.9%—

Operating margin-0.3%—

Net margin-10.5%+26.2pp

FCF margin1%—

Returns & leverage

See full

Return on equity-3.9%+4.7pp

Debt / equity0×0.0×

Current ratio10.3×+2.8×

Where this comes from

Reported directly by Ceva in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross.

The official record: Ceva’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ceva's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ceva's granted (in shares)?: Ceva (CEVA) reported granted (in shares) of 0 in Q1 2026.
What does granted (in shares) mean?: The total number of stock option shares granted to employees and directors during the reporting period. This metric provides insight into the company's equity-based incentive strategy and potential future dilution.